Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to evaluate the catheter related bladder discomfort in patients who will undergoing TUR-P operation. The main questions it aims to answer are:
Is sacral ESPB effective on the pudendal nerve dermatome?
Is sacral ESPB as useful as pudendal block on CRBD? Participants will be divided into two groups and the first group will receive sacral espb after TUR-p operation and the second group will receive pudendal block. Investigators will be present for 24 hours
This is a prospective,randomised,double-blind, single-centre,study aiming to compare the effectiveness of US guided bilateral sacral ESPB and US guided bilateral pudendal block on CRBD and pain after TUR-P. 54 patients will be included in the study and divided into two groups. All patients will be standardly monitored and will receive general anaesthesia. At the end of the cases, sacral ESPB will be applied to the first group and pudendal block to the second group, and the patients and the data questioner physician will be blinded to the study.
Primary and secondary outcomes will be questioned for 24 hours and statistics will be made according to the result.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| espb group | Experimental | Block will be performed with median technique at the level of sacral 2nd vertebrae. |
|
| pudendal group | Active Comparator | Bilateral transperineal block will be performed |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sacral ESP Block | Procedure | Sacral ESPB median approach, 40 ml %0,25 Bupivacaine |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Catheter related bladder discomfort, 0:no discomfort 4:worst discomfort | It was evaluated with a 4-point scoring system developed and first used by Agarwall et al. . No symptoms: 0, Mild: mild discomfort that can be tolerated, Moderate: discomfort is present but not accompanied by behavioural reactions, Severe: discomfort is very severe and accompanied by body movements indicating that the patient cannot bear it. | baseline ,and 24 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Numerical Rating Scale,0 :no pain 10:worst pain | The NRS score of the patients was "0: no pain, 10: the most severe pain experienced". An NRS value of 4 and above indicates that the pain is severe and rescue analgesia is required. | baseline, and 24 hours |
Not provided
Inclusion Criteria:
- American Society of Anesthesiologist (ASA) Physical status 1-3
Exclusion Criteria:
Only males have got prostate
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Bilge Olgun Keleş | Giresun University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Giresun Research and Training Hospital | Merkez | Giresun | 28100 | Turkey (Türkiye) |
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Pudendal Block |
| Procedure |
Bilateral pudendal block, 10 ml %0,25 bupivacaine |
|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |